-
Risk of serious errors with piperacillin/tazobactam highlighted in Drug Safety Update
9 Jan 09 | 15.52 | England Scotland Wales
Clearer labelling of reconstituted generic piperacillin/tazobactam products has been called for because of the risk of serious medication errors due to differing compatibility of generic piperacillin/tazobactam products with other medicines compared with the brand leader Tazocin more >
-
New rules mean athletes can declare non-systemic glucocorticosteroid use online
9 Jan 09 | 15.47 | England Scotland Wales
Athletes are no longer required to apply for approval to use non-systemic glucocorticosteroids, but can declare that they are using the prohibited substances in a new scheme being launched by UK Sport more >
-
New anticoagulants reviewed at US event
9 Jan 09 | 15.46 | International
There are good data to support using rivaroxaban to prevent deep vein thrombosis and promising results for using it to treat venous thromboembolism (VTE). However, there is currently insufficient evidence to recommend rivaroxaban for thromboprophylaxis in patients with atrial fibrillation
more > -
Depression with Parkinson’s disease responds better to TCA than SSRI
9 Jan 09 | 15.46 | International
Parkinson’s disease (PD) patients with depression may respond better to tricyclic antidepressants (TCAs) than to the widely prescribed selective serotonin reuptake inhibitors (SSRIs), according to the results of a study published online
more > -
Antidepressant use in Scotland increases
9 Jan 09 | 15.45 | Scotland
Prescribing of antidepressants rose in NHS Scotland by 4.7 per cent between 2006–07 and 2007–08, according to official figures more >
-
Genetics could affect response to clopidogrel
9 Jan 09 | 15.45 | International
The clinical effectiveness of clopidogrel in the treatment of cardiovascular disease may be affected by patients’ genetic make-up, according to two studies published online
more > -
Fish oil supplements reviewed
9 Jan 09 | 15.44 | International
Use of fish oil supplements is associated with reduced death from cardiac causes but has no effect on arrhythmias or all-cause mortality, a meta-analysis published online indicates
more > -
Multiple corticosteroid doses do not prevent premature births
9 Jan 09 | 15.42 | International
Babies treated with multiple doses of corticosteroid in utero were not found to be at reduced risk of preterm birth in a recent study
more > -
Gemcitabine/carboplatin similar to cisplatin/etoposide
9 Jan 09 | 15.40 | International
Gemcitabine with carboplatin (GC) offers similar benefits in overall and progression-free survival for patients with poor-prognosis small-cell lung cancer as does cisplatin with etoposide (CE), concludes a 241-patient study published
more > -
Beta-blockers without evidence base could be used for heart failure
9 Jan 09 | 15.39 | International
Beta-blockers without an evidence base in heart failure could still be used for such patients, two comparative studies published suggest
more >
Hello guest, welcome to PJ online
gateway to the world of pharmacy and medicines
